<DOC>
	<DOCNO>NCT02405403</DOCNO>
	<brief_summary>Neuroinflammation , characterize particular microglia activation , essential component Amyotrophic Lateral Sclerosis ( ALS ) pathogenesis . Translocator Protein ( TSPO ) recognize specific sensitive biomarker neuroinflammation , reflect disease activity . An experimental radiopharmaceutical specific TSPO expression , namely [ 18F ] DPA714 , allow quantify microglial activation use Positon Emission Tomography ( PET ) imaging . The purpose study longitudinally correlate spatial distribution neuroinflammation pro- anti-inflammatory state activate microglia cell ALS , order evaluate neurotoxic neuroprotective microglia activity , complementary approach 20 ALS patient : - vitro : measuring concentration several pro- anti-inflammatory cytokine secrete microglial cell cerebrospinal fluid ( CSF ) . - vivo : [ 18F ] DPA714 PET image . These assay perform framework clinical follow-up ALS patient , diagnosis ALS disease 6 month latter .</brief_summary>
	<brief_title>Microglial Activation Role In ALS ( MARIA )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Signed informed consent Age ≥ 18 year old Patient probable definite sporadic Amyotrophic Lateral Sclerosis ( ALS ) form accord modify criterion El Escorial Treated riluzole 2 week Evolution le 18 month MiniMental State Examination ( MMS ) score ≥ 26 Frontal Assessment Battery ( FAB ) ( normal ) Affiliated social security system Another unbalanced progressive pathology Vascular disease ( hypertension , diabetes , smoking , dyslipidemia ) unbalance Forced vital capacity &lt; 75 % Weight loss &gt; 10 % weight disease Status `` low affinity binder '' `` mixed affinity binder '' , TSPO respect [ 18 F ] DPA714 , interfere process neuroinflammation : drug antiinflammatory drug ( NSAIDs , corticosteroid , azathioprine , antitumor necrosis factor ( TNF ) , antibiotic ) Benzodiazepine week PET scan [ 18F ] DPA714 give potential consequence TSPO receiver Contraindications MRI patient : 1 . Metallic foreign body eye . 2 . Any implanted electronic medical irremovably ( pacemaker , neurostimulator , cochlear implant ... ) 3 . Metal heart valve , 4 . Vascular clip formerly locate cranial aneurysm . Treatment month PET scan [ 18F ] DPA714 antagonist NmethylDaspartate ( NMDA ) ( memantine ) Pregnant woman , lactate woman , woman age procreation without reliable contraception without history hysterectomy ◦Person guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>amyotrophic lateral sclerosis disease</keyword>
	<keyword>PET</keyword>
	<keyword>microglial activation</keyword>
</DOC>